Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2024-08-16
DOI
https://doi.org/10.1016/j.eclinm.2024.102784
Citations
17
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
5.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension

Thomas E Serena, Vincent Brandenburg, Dinesh K. Chatoth, Jeffrey L. Hymes et al.
17 citations
EClinicalMedicine
Parathyroid Disorders and Treatments
5.77
article

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension

Thomas E Serena, Vincent Brandenburg, Dinesh K. Chatoth, Jeffrey L. Hymes, Glenn M. Chertow, Sagar U. Nigwekar, Joan Perelló, Gabriela Alperovich, Sharon M. Moe, Smeeta Sinha, Lisa J. Gould, Kevin J. Carroll, L Keller, George R. Aronoff, Alex Gold
article en
17 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 75
Harvard University (US), Manchester Academic Health Science Centre (GB), Salford Royal NHS Foundation Trust (GB), Sierra Nevada College (US), University of Manchester (GB), Massachusetts General Hospital (US), South Shore Hospital (US), KCI (Ireland) (IE), Salford Royal Hospital (GB), Michigan Medicine (US), VA Center for Clinical Management Research (US), SerenaGroup Research Institute (US), Fresenius Medical Care (United States) (US), Health Research Institute of the Balearic Islands (ES), Clinica Rotger (ES), Research Institute of Health Sciences (ES), Colorado Kidney Care (US), Klinikum Rheine (DE), Vifor Pharma (United States) (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), Stanford University (US)
Openalex Percentile: Top 3%
Parathyroid Disorders and Treatments
5.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.